Pharmacokinetic and clinical studies on timentin in ear, nose and throat infections.
Federspil
P
P
University ORL Clinic, 6650 Homburg/Saar, FRG.
Koch
A
A
Schedler
M
M
Tiesler
E
E
D019980:Amoxicillin-Potassium Clavulanate Combination / Q000493:pharmacokinetics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D002969:Clavulanic Acids / Q000493:pharmacokinetics / Q000627:therapeutic use; D004427:Ear Diseases / Q000188:drug therapy* / Q000382:microbiology*; D005260:Female; D006801:Humans; D007239:Infections / Q000188:drug therapy; D008297:Male; D009668:Nose Diseases / Q000188:drug therapy* / Q000382:microbiology; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000382:microbiology; D013982:Ticarcillin / Q000493:pharmacokinetics / Q000627:therapeutic use; D014069:Tonsillitis / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D019980:Amoxicillin-Potassium Clavulanate Combination; C043215:ticarcillin-clavulanic acid; D013982:Ticarcillin